Literature DB >> 17139261

p53 mediates the negative regulation of MDM2 by orphan receptor TR3.

Bi-xing Zhao1, Hang-zi Chen, Na-zi Lei, Gui-deng Li, Wen-xiu Zhao, Yan-yan Zhan, Bo Liu, Sheng-cai Lin, Qiao Wu.   

Abstract

MDM2 is an oncoprotein whose transforming potential is activated by overexpression. The expression level of MDM2 is negatively regulated by orphan receptor TR3 that mainly acts as a transcriptional factor to regulate gene expression. However, the underlying mechanism is largely unclear. Here, we present the first evidence that inhibition of TR3 on MDM2 is mediated by p53. We found that TR3 directly interacts with p53 but not MDM2, and such interaction is critical for TR3 to inhibit MDM2 expression. TR3 downregulates p53 transcriptional activity by blocking its acetylation, leading to a decrease on the transcription level of MDM2. Furthermore, TR3 binding to p53 obstructs its ubiquitination and degradation induced by MDM2, resulting in the MDM2 ubiquitination and degradation. In addition, TR3 could enhance p53-mediated apoptosis induced by UV irradiation. Taken together, our findings demonstrate that p53 mediates the suppression of TR3 on MDM2 at both transcriptional and post-transcriptional level and suggest TR3 as a potential target to develop new anticancer agents that restrict MDM2-induced tumor progression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17139261      PMCID: PMC1698882          DOI: 10.1038/sj.emboj.7601435

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  47 in total

1.  The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation.

Authors:  J Momand; G P Zambetti; D C Olson; D George; A J Levine
Journal:  Cell       Date:  1992-06-26       Impact factor: 41.582

2.  RXRalpha acts as a carrier for TR3 nuclear export in a 9-cis retinoic acid-dependent manner in gastric cancer cells.

Authors:  Xiao-Feng Lin; Bi-Xing Zhao; Hang-Zhi Chen; Xiao-Feng Ye; Chao-Yi Yang; Hai-Ying Zhou; Ming-Qing Zhang; Sheng-Cai Lin; Qiao Wu
Journal:  J Cell Sci       Date:  2004-10-19       Impact factor: 5.285

3.  Abnormal structure and expression of p53 gene in human hepatocellular carcinoma.

Authors:  B Bressac; K M Galvin; T J Liang; K J Isselbacher; J R Wands; M Ozturk
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

4.  A gene inducible by serum growth factors encodes a member of the steroid and thyroid hormone receptor superfamily.

Authors:  T G Hazel; D Nathans; L F Lau
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

5.  YY1 inhibits the activation of the p53 tumor suppressor in response to genotoxic stress.

Authors:  Eva Grönroos; Alexei A Terentiev; Tanel Punga; Johan Ericsson
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-04       Impact factor: 11.205

6.  TR3/Nur77 in colon cancer cell apoptosis.

Authors:  Andrew J Wilson; Diego Arango; John M Mariadason; Barbara G Heerdt; Leonard H Augenlicht
Journal:  Cancer Res       Date:  2003-09-01       Impact factor: 12.701

7.  Identification of a new member of the steroid receptor super-family by cloning and sequence analysis.

Authors:  C Chang; J Kokontis
Journal:  Biochem Biophys Res Commun       Date:  1988-09-15       Impact factor: 3.575

8.  Mitogenic effect of orphan receptor TR3 and its regulation by MEKK1 in lung cancer cells.

Authors:  Siva Kumar Kolluri; Nathalie Bruey-Sedano; Xihua Cao; Bingzhen Lin; Feng Lin; Young-Hoon Han; Marcia I Dawson; Xiao-kun Zhang
Journal:  Mol Cell Biol       Date:  2003-12       Impact factor: 4.272

9.  Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumor cell line.

Authors:  S S Fakharzadeh; S P Trusko; D L George
Journal:  EMBO J       Date:  1991-06       Impact factor: 11.598

10.  mdm2 expression is induced by wild type p53 activity.

Authors:  Y Barak; T Juven; R Haffner; M Oren
Journal:  EMBO J       Date:  1993-02       Impact factor: 11.598

View more
  35 in total

1.  p53 and miR-34a Feedback Promotes Lung Epithelial Injury and Pulmonary Fibrosis.

Authors:  Shwetha K Shetty; Nivedita Tiwari; Amarnath S Marudamuthu; Bijesh Puthusseri; Yashodhar P Bhandary; Jian Fu; Jeffrey Levin; Steven Idell; Sreerama Shetty
Journal:  Am J Pathol       Date:  2017-03-06       Impact factor: 4.307

2.  Orphan receptor TR3 enhances p53 transactivation and represses DNA double-strand break repair in hepatoma cells under ionizing radiation.

Authors:  Bi-xing Zhao; Hang-zi Chen; Xiao-dan Du; Jie Luo; Jian-ping He; Rong-hao Wang; Yuan Wang; Rong Wu; Ru-rong Hou; Ming Hong; Qiao Wu
Journal:  Mol Endocrinol       Date:  2011-06-09

Review 3.  The regulation of MDM2 oncogene and its impact on human cancers.

Authors:  Yuhan Zhao; Haiyang Yu; Wenwei Hu
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2014-01-03       Impact factor: 3.848

4.  Toll-like receptor 3 (TLR3) induces apoptosis via death receptors and mitochondria by up-regulating the transactivating p63 isoform alpha (TAP63alpha).

Authors:  Ruili Sun; Yu Zhang; Qingshan Lv; Bei Liu; Miao Jin; Weijia Zhang; Qing He; Minjie Deng; Xueting Liu; Guancheng Li; Yuehui Li; Guohua Zhou; Pingli Xie; Xiumei Xie; Jinyue Hu; Zhaojun Duan
Journal:  J Biol Chem       Date:  2011-03-02       Impact factor: 5.157

5.  Orphan receptor NR4A3 is a novel target of p53 that contributes to apoptosis.

Authors:  Olga Fedorova; Alexey Petukhov; Alexandra Daks; Oleg Shuvalov; Tatyana Leonova; Elena Vasileva; Nikolai Aksenov; Gerry Melino; Nikolai A Barlev
Journal:  Oncogene       Date:  2018-11-19       Impact factor: 9.867

6.  Diindolylmethane analogs bind NR4A1 and are NR4A1 antagonists in colon cancer cells.

Authors:  Syng-Ook Lee; Xi Li; Erik Hedrick; Un-Ho Jin; Ronald B Tjalkens; Donald S Backos; Li Li; Yi Zhang; Qiao Wu; Stephen Safe
Journal:  Mol Endocrinol       Date:  2014-08-06

7.  Predicted functions of MdmX in fine-tuning the response of p53 to DNA damage.

Authors:  Sohyoung Kim; Mirit I Aladjem; Geoffrey B McFadden; Kurt W Kohn
Journal:  PLoS Comput Biol       Date:  2010-02-05       Impact factor: 4.475

Review 8.  Minireview: role of orphan nuclear receptors in cancer and potential as drug targets.

Authors:  Stephen Safe; Un-Ho Jin; Erik Hedrick; Alexandra Reeder; Syng-Ook Lee
Journal:  Mol Endocrinol       Date:  2013-12-02

9.  Modulation of microRNA processing by p53.

Authors:  Hiroshi I Suzuki; Kaoru Yamagata; Koichi Sugimoto; Takashi Iwamoto; Shigeaki Kato; Kohei Miyazono
Journal:  Nature       Date:  2009-07-23       Impact factor: 49.962

10.  Regulation of peroxisome proliferator-activated receptor-alpha by MDM2.

Authors:  Lakshmi Gopinathan; Daniel B Hannon; Jeffrey M Peters; John P Vanden Heuvel
Journal:  Toxicol Sci       Date:  2008-12-22       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.